Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Prenetics Global Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/14/2023 6-K Quarterly results
Docs: "FORM 6-K",
"Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results New Business Strategy Focused on Precision Oncology"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology LONDON AND HONG KONG, March 2, 2023 - Prenetics Global Limited , a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics' diagnostic cancer genomics platform. Prenetics has been at the forefront of genomic and diagnostic testing, providing a wide range of genetic testing services to individuals and healthcare professionals around the world. The SAB includes a diverse group of highly respected experts in oncology and genomics, each with unique expertise and backgrounds in the f..."
01/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA"
01/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors"
12/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology"
11/30/2022 6-K Quarterly results
09/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
09/09/2022 6-K Quarterly results
06/06/2022 6-K Quarterly results
05/19/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Rings the Opening Bell and Debuts on Nasdaq · Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under ticker “PRE” · At Least US$260M of Proceeds from the Business Combination, Cash and Trade Receivables to Support Prenetics Growth · Proceeds will allow Prenetics to continue its significant growth trajectory and will be used for strategic acquisitions, R&D, product rollout and geographic expansion into EMEA and Southeast Asia LONDON and HONG KONG, May 18, 2022 – Prenetics Group Limited , a global leader in genomic and diagnostic testing, and Artisan Acquisition Corp. , a special purpose acquisition company privately founded by renowned cultural entrepreneur Adrian Cheng, today completed their previously ann..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy